Chief operating officer Michael Mullette – a pharma industry veteran with experience at Moderna and Sanofi – has been named interim CEO, ...

Only a few weeks later, Lykos’ CEO, Amy Emerson, decided to step down, with Michael Mullette becoming interim CEO to lead further discussions with the FDA over the next steps for midomafetamine.

This is a list of today's New South Wales Civil and Administrative Tribunal consumer and commercial hearings at Parramatta : ...